Clinical trials recruiting for MSI-H
Fewer than 3 recruiting trials found.
2
Recruiting trials
0
US states with sites
1
Countries
0%
Accept healthy volunteers
Phase breakdown
Phase 1 1Phase 2 2
Drugs and treatments being studied
| Intervention | Trials |
|---|---|
| Intensive immunotherapy plus anti-VEGF treatment, up to 24 weeks | 1 |
| PD1/PDL1 antibody monotherapy, up to 24 weeks | 1 |
| Sintilimab | 1 |
| hypofractionated radiotherapy | 1 |
Self-screener
Recruiting trials
- Immune Checkpoint Inhibitors for Organ Preservation in Non-metastatic dMMR/MSI-H Gastric or Colon Cancers
- Sintilimab Plus Hypofractionated Radiotherapy for MSI-H/dMMR Rectal Cancer
Related conditions
Trials recruiting for MSI-H often also study these conditions. Each links to its own recruiting-trial list.
Colorectal cancer 1359Rectal cancer 152Radiotherapy 31Gastric cancer 91DMMR Cancer 3Colon cancer 96Anti-PD-1 Antibody 3
Common questions
Are these trials free to join?
Study-related care in a clinical trial is usually provided at no cost to participants, and some trials reimburse travel. Costs vary by study - the trial team will explain what is and is not covered. Confirm this directly with them.
How do I know if I am eligible for MSI-H trials?
Each trial lists inclusion and exclusion criteria. The screener above checks stated age and sex only. The full eligibility (your medical history, current medications, test results) is assessed by the study team. Open any trial to read its criteria, then contact the site.
Is this list complete?
No. For the full list, search ClinicalTrials.gov.